A talented trifecta of Salk cancer researchers—Geoffrey Wahl, Amy Rommel and Reuben Shaw (above, from left)—drew 75 attendees to the Salkexcellerators program in January at the Institute. The scientists spoke of their groundbreaking work pursuing the origins of cancers and better understanding the tumor suppressor P53 and glioblastoma. Also announced was a $20,000 grant from Merck to help fund early career scientists.

Salkexcellerators, the next generation of community members committed to supporting scientific discovery at Salk, meets throughout the year.

To learn more:
Contact Jane Rhett,
director of Annual Giving
(858) 453-4100 x1521
jrhett@salk.edu
www.salk.edu/salkexcellerators